Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain

Neuroscience Letters

Volumn 276, Issue 1, 1999, Pages 68-70

  Yamakawa, Takahiro ^a   Kotake, Yaichiro ^b   Fujitani, Morioki ^c   Shintani, Hideaki ^c   Makino, Yukiko ^a   Ohta, Shigeru ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

1 Benzyl 1,2,3,4 tetrahydroisoquinoline; 1 Methyl 1,2,3,4 tetrahydroisoquinoline synthesizing enzyme; Endogenous tetrahydroisoquinolines; Monkey brain; Parkinsonism; Regional distribution in brain

Indexed keywords

1 BENZYL 1,2,3,4 TETRAHYDROISOQUINOLINE; 1,2,3,4 TETRAHYDRO 1 METHYLISOQUINOLINE; TETRAHYDROISOQUINOLINE; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN REGION; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; HISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MONKEY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; THALAMUS;

ANIMALS; BRAIN; ISOQUINOLINES; MACACA FASCICULARIS; PARKINSONIAN DISORDERS; TETRAHYDROISOQUINOLINES; TISSUE DISTRIBUTION;

EID: 0032749525     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00786-7     Document Type: Article

References (16)

1. Collins M.A., Neafsey E.J., Matsubara K., Cobuzzi R.J. Jr., Rollema H. Indole-N-methylated β-carbolinium ions as potential brain-bioactivated neurotoxins. Brain Res. 570:1992;154-160.
2. Igarashi K., Matsubara K., Kasuya F., Fukui M., Idzu T., Castagnoli N.J. Effect of a pyridinium metabolite derived from haloperidol on the activities of striatal tyrosine hydroxylase in freely moving rats. Neurosci. Lett. 214:1996;183-186.
3. Kawai H., Makino Y., Hirobe M., Ohta S. Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism. J. Neurochem. 70:1998;745-751.
4. Kikuchi K., Nagatsu Y., Makino Y., Mashino T., Ohta S., Hirobe M. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds 1,2,3,4-tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline. Drug Metab. Dispos. 19:1991;257-262.
5. Kohno M., Ohta S., Hirobe M. Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain. Biochem. Biophys. Res. Commun. 140:1986;448-454.
6. Kotake Y., Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J. Neurochem. 65:1995;2633-2638.
7. Kotake Y., Yoshida M., Ogawa M., Tasaki Y., Hirobe M., Ohta S. Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate. Neurosci. Lett. 217:1996;69-71.
8. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
9. Makino Y., Tasaki Y., Ohta S., Hirobe M. Confirmation of the enantiomers of 1-methyl-1,2,3,4-tetrahydroisoquinoline in the mouse brain and foods applying gas chromatography/mass spectrometry with negative ion chemical ionization. Biomed. Environ. Mass Specrom. 19:1990;415-419.
10. Matsubara K., Gonda T., Sawada H., Uezono T., Kobayashi Y., Kawamura T., Ohtaki K., Kimura K., Akaike A. Endogenous occurring β-carboline induces parkinsonism in non-primate animals: a possible causative protoxin in idiopathic Parkinson's disease. J. Neurochem. 70:1998;727-735.
11. Matsubara K., Senda T., Uezono T., Fukushima S., Ohta S., Igarashi K., Naoi M., Yamashita Y., Ohtaki K., Hayase N., Akutsu S., Kimura K. Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter. Eur. J. Pharmacol. 348:1998;77-84.
12. Ohta S., Kohno M., Makino Y., Tachikawa O., Hirobe M. Tetrahydroisoquinoline and 1-methyltetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease. Biomed. Res. 8:1987;453-456.
13. Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Methyltetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. J. Neurochem. 57:1991;1940-1943.
14. Tipton K.F., Singer T.P. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61:1993;1191-1206.
15. Yamakawa T., Ohta S. Isolation of 1-methyl-1,2,3,4-tetrahydroisoquinoline-synthesizing enzyme from rat brain: a possible Parkinson's disease-preventing enzyme. Biochem. Biophys. Res. Commun. 236:1997;676-681.
16. Yamakawa T., Ohta S. Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction. Neurosci. Lett. 259:1999;157-160.